Undisclosed PD-L1 Targeted ADCplex
/ HighField Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2026
PD-L1–Targeted ADCplex Delivering a Pan-KRAS Molecular Glue and Irinotecan Demonstrates Potent Antitumor Activity With Reduced Toxicity in Preclinical Pancreatic Cancer Models
(ESMO 2026)
- No abstract available
ADC • Preclinical • Oncology • Pancreatic Cancer • Solid Tumor • KRAS • PD-L1
1 to 1
Of
1
Go to page
1